A detailed history of Alpha Cubed Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alpha Cubed Investments, LLC holds 4,404 shares of BMY stock, worth $256,444. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,404
Previous 4,957 11.16%
Holding current value
$256,444
Previous $205,000 10.73%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$39.66 - $51.75 $21,931 - $28,617
-553 Reduced 11.16%
4,404 $227,000
Q2 2024

Jul 15, 2024

BUY
$40.25 - $52.99 $25,116 - $33,065
624 Added 14.4%
4,957 $205,000
Q1 2024

Apr 22, 2024

BUY
$47.98 - $54.4 $207,897 - $235,715
4,333 New
4,333 $234,000
Q3 2023

Oct 19, 2023

SELL
$57.89 - $64.73 $156,939 - $175,483
-2,711 Reduced 20.08%
10,788 $626,000
Q2 2023

Jul 20, 2023

SELL
$63.71 - $70.74 $17,010 - $18,887
-267 Reduced 1.94%
13,499 $863,000
Q1 2023

Apr 26, 2023

SELL
$65.71 - $74.53 $192,333 - $218,149
-2,927 Reduced 17.53%
13,766 $954,000
Q4 2022

Jan 25, 2023

BUY
$68.48 - $81.09 $47,936 - $56,763
700 Added 4.38%
16,693 $0
Q3 2022

Nov 03, 2022

SELL
$0.13 - $76.84 $1,511 - $893,341
-11,626 Reduced 42.09%
15,993 $1.14 Million
Q2 2022

Jul 22, 2022

BUY
$72.62 - $79.98 $9,077 - $9,997
125 Added 0.45%
27,619 $2.13 Million
Q1 2022

Apr 22, 2022

BUY
$61.48 - $73.72 $1.02 Million - $1.22 Million
16,553 Added 151.29%
27,494 $2.01 Million
Q4 2021

Jan 19, 2022

BUY
$53.63 - $62.52 $307,943 - $358,989
5,742 Added 110.44%
10,941 $682,000
Q3 2021

Oct 26, 2021

SELL
$59.17 - $69.31 $183,545 - $214,999
-3,102 Reduced 37.37%
5,199 $308,000
Q1 2021

Apr 23, 2021

SELL
$59.34 - $66.74 $87,763 - $98,708
-1,479 Reduced 15.12%
8,301 $524,000
Q4 2020

Jan 29, 2021

SELL
$57.74 - $65.43 $240,256 - $272,254
-4,161 Reduced 29.85%
9,780 $607,000
Q3 2020

Oct 14, 2020

SELL
$57.43 - $63.64 $34,228 - $37,929
-596 Reduced 4.1%
13,941 $841,000
Q2 2020

Jul 13, 2020

BUY
$54.82 - $64.09 $244,003 - $285,264
4,451 Added 44.13%
14,537 $855,000
Q1 2020

Apr 10, 2020

BUY
$46.4 - $67.43 $29,556 - $42,952
637 Added 6.74%
10,086 $562,000
Q4 2019

Jan 17, 2020

BUY
$49.21 - $64.19 $251,069 - $327,497
5,102 Added 117.37%
9,449 $607,000
Q3 2019

Oct 18, 2019

SELL
$42.77 - $50.71 $8,126 - $9,634
-190 Reduced 4.19%
4,347 $220,000
Q2 2019

Jul 19, 2019

SELL
$44.62 - $49.34 $39,801 - $44,011
-892 Reduced 16.43%
4,537 $206,000
Q1 2019

Apr 26, 2019

SELL
$45.12 - $53.8 $37,855 - $45,138
-839 Reduced 13.39%
5,429 $259,000
Q4 2018

Jan 29, 2019

SELL
$48.76 - $63.23 $577,220 - $748,516
-11,838 Reduced 65.38%
6,268 $326,000
Q3 2018

Oct 25, 2018

BUY
$55.19 - $62.25 $417,346 - $470,734
7,562 Added 71.72%
18,106 $983,000
Q2 2018

Jul 26, 2018

BUY
$50.53 - $62.98 $26,477 - $33,001
524 Added 5.23%
10,544 $584,000
Q1 2018

May 09, 2018

SELL
$59.92 - $68.98 $2,037 - $2,345
-34 Reduced 0.34%
10,020 $634,000
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $63,955 - $69,728
1,067 Added 11.87%
10,054 $616,000
Q3 2017

Oct 23, 2017

BUY
$55.23 - $63.74 $496,352 - $572,831
8,987
8,987 $573,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alpha Cubed Investments, LLC Portfolio

Follow Alpha Cubed Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Cubed Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Cubed Investments, LLC with notifications on news.